Treatment for Nontype 1 Retinopathy of Prematurity by Intravitreal Injection of Antivascular Endothelial Growth Factor Drugs

Table 3

Characteristics of pathological manifestation of nontype 1 ROP receiving treatment.

Characteristics		Nontype 1 treated eyes (N  = 65)
		N	%
Zone	I	2	3.1
	II	63	96.9
	Posterior II	5	7.7
	Periphery II	58	89.2
Stage	1	2	3.1
	2	40	61.5
	3	23	35.4
Plus disease^α	−	7	10.8
	±	58	89.2
Reasons	Preplus	58	89.2
	Ridge aggravation	22	33.8
	Contralateral eye	9	13.8
	Follow-up time ≥ PMA44w	8	12.3
	Logistical considerations	4	6.2

^α±, referred to preplus diseases.